Phillips-Medisize today said that it acquired exclusive ownership of patents supporting a mini-tablet dispenser from Global Pharmaceutical Company.
The mini-tablet dispenser is mounted on top of a standard tablet bottle where a patient or caregiver can count and dispense mini-tablets in predetermined amounts from one to 20 tablets. It supports tablets sized 2×2 mm to 2.3×2.3 mm. The dispenser also allows users to visually confirm a measured tablet count before dispensing. It also reduces damage and crushing of tablets during dispensing.
“Through its unique working principle, the mini-tablet dispenser will be valuable in pediatrics, geriatrics and oncology where patients often require highly flexible oral dosing based on age, weight and other variables,” Phillips-Medisize president and CEO Matt Jennings said in a press release. “Furthermore, in smaller patient populations, the option to flexibly count to combine incremental mini-tablet doses offers an advantage over-preparing multiple fixed oral tablet dose strengths.”
Phillips-Medisize started industrialization preparations and plans to make the dispenser available globally in early 2020.